| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2020 and 2019:
|
|
|
For the years ended November 30,
|
|
|
|
|
2020
|
|
|
2019
|
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
30,176,852
|
|
|
$
|
30,991,972
|
|
|
PrepaCyte CB
|
|
|
244,187
|
|
|
|
172,395
|
|
|
Public cord blood banking
|
|
|
726,554
|
|
|
|
652,204
|
|
|
Total net revenue
|
|
$
|
31,147,593
|
|
|
$
|
31,816,571
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
7,731,227
|
|
|
$
|
8,490,824
|
|
|
PrepaCyte CB
|
|
|
156,111
|
|
|
|
249,487
|
|
|
Public cord blood banking
|
|
|
1,770,104
|
|
|
|
1,295,864
|
|
|
Total cost of sales
|
|
$
|
9,657,442
|
|
|
$
|
10,036,175
|
|
|
Operating profit:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
9,928,886
|
|
|
$
|
8,152,475
|
|
|
PrepaCyte CB
|
|
|
60,499
|
|
|
|
(113,346
|
)
|
|
Public cord blood banking
|
|
|
(2,327,788
|
)
|
|
|
(2,976,423
|
)
|
|
Total operating profit
|
|
$
|
7,661,597
|
|
|
$
|
5,062,706
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
344,711
|
|
|
$
|
365,057
|
|
|
PrepaCyte CB
|
|
|
27,578
|
|
|
|
36,254
|
|
|
Public cord blood banking
|
|
|
-
|
|
|
|
-
|
|
|
Total depreciation and amortization
|
|
$
|
372,289
|
|
|
$
|
401,311
|
|
|
Interest expense:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
1,544,017
|
|
|
$
|
1,703,446
|
|
|
PrepaCyte CB
|
|
|
-
|
|
|
|
-
|
|
|
Public cord blood banking
|
|
|
-
|
|
|
|
-
|
|
|
Total interest expense
|
|
$
|
1,544,017
|
|
|
$
|
1,703,446
|
|
The following table shows the assets by segment as of November 30, 2020 and November 30, 2019:
|
|
|
2020
|
|
|
2019
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service
|
|
$
|
34,215,780
|
|
|
$
|
28,975,002
|
|
|
PrepaCyte CB
|
|
|
302,683
|
|
|
|
289,804
|
|
|
Public cord blood banking
|
|
|
11,681,631
|
|
|
|
13,621,354
|
|
|
Total assets
|
|
$
|
46,200,094
|
|
|
$
|
42,886,160
|
|
|